Skip to main content
Premium Trial:

Request an Annual Quote

Yasuhiro Kuroda, Douglas Lauffenburger, Karen Gibson, Todd Pierce, Anthony Recupero


Yasuhiro Kuroda, manager of the life sciences business for Japanese software distributor Infocom, will leave the company on April 1 to serve as director of sales and enterprise for Bioinformatics Institute Global Good Ltd., a venture company related to Japan’s National Institute of Genetics. Kuroda will also serve as a sales representative for Geneva Bioinformatics in Japan.

Genstruct has appointed Douglas Lauffenburger to its board of directors. Lauffenburger is the director of the biological engineering division at MIT, and is director of the executive committee for MIT’s Computational and Systems Biology Initiative.

Invitrogen has tapped Karen Gibson as senior VP of information technology and CIO. Gibson was most recently VP of global e-business and CIO for General Electric’s Medical Systems Information Technologies division. She is the third executive to join Invitrogen from GE’s Medical Systems IT division, joining Gregory Lucier, CEO, and Claude Benchimol, senior vice president of R&D.

Todd Pierce has been promoted to vice president of corporate information technology at Genentech. He was previously head of CIT operations at the company.

Anthony Recupero has joined MaxCyte as vice president for business development. He was previously senior director for business development at Gene Logic.

Filed under

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.